Accelerate Diagnostics Inc. (AXDX) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Accelerate Diagnostics In...

    NASDAQ: AXDX · Real-Time Price · USD
    0.03
    -0.00 (-11.76%)
    At close: May 14, 2025, 3:59 PM

    Accelerate Diagnostics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 11.7M 12.06M 12.75M 11.78M
    Cost of Revenue
    		 8.99M 9.51M 9.45M 12.16M
    Gross Profit
    		 2.7M 2.55M 3.3M -381K
    Operating Income
    		 -35.31M -54.03M -62.8M -71.56M
    Interest Income
    		 703K 1.12M 551K 88K
    Pretax Income
    		 -50.11M -60.77M -62.57M -77.66M
    Net Income
    		 -50.05M -61.62M -62.49M -77.7M
    Selling & General & Admin
    		 21.33M 31.23M 39.19M 49.24M
    Research & Development
    		 16.69M 25.35M 26.91M 21.94M
    Other Expenses
    		 n/a n/a -227K -20K
    Operating Expenses
    		 38.01M 56.58M 66.11M 71.18M
    Interest Expense
    		 13.12M 7.74M 3.77M 15.54M
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 47.01M 66.09M 75.56M 83.34M
    Income Tax Expense
    		 -66K 850K -77K 45K
    Shares Outstanding (Basic)
    		 23.3M 12.48M 8.22M 6.17M
    Shares Outstanding (Diluted)
    		 23.3M 12.48M 8.22M 6.17M
    EPS (Basic)
    		 -2.15 -4.94 -7.61 -12.59
    EPS (Diluted)
    		 -2.15 -4.94 -7.61 -12.59
    EBITDA
    		 -33.57M -49.77M -55.8M -59.59M
    EBIT
    		 -36.99M -53.02M -58.8M -62.11M
    Depreciation & Amortization
    		 3.42M 3.25M 3M 2.52M

    Add to Watchlist